Pharmacokinetics and bioavailability of intravenous, oral, and rectal nitrazepam in humans. 1982

R Jochemsen, and J J Hogendoorn, and J Dingemanse, and J Hermans, and J K Boeijinga, and D D Breimer

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009567 Nitrazepam A benzodiazepine derivative used as an anticonvulsant and hypnotic. Nitrodiazepam,Alodorm,Dormalon,Dormo-Puren,Eatan,Imadorm,Imeson,Mogadon,Nitrazadon,Nitrazep,Nitrazepam AL,Nitrazepam-Neuraxpharm,Novanox,Radedorm,Remnos,Rhoxal-Nitrazepam,Serenade,Somnite,Nitrazepam Neuraxpharm,Rhoxal Nitrazepam
D012007 Rectum The distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL. Rectums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

R Jochemsen, and J J Hogendoorn, and J Dingemanse, and J Hermans, and J K Boeijinga, and D D Breimer
July 1983, Journal of pharmaceutical sciences,
R Jochemsen, and J J Hogendoorn, and J Dingemanse, and J Hermans, and J K Boeijinga, and D D Breimer
January 1988, European journal of clinical pharmacology,
R Jochemsen, and J J Hogendoorn, and J Dingemanse, and J Hermans, and J K Boeijinga, and D D Breimer
January 1979, Journal of pharmaceutical sciences,
R Jochemsen, and J J Hogendoorn, and J Dingemanse, and J Hermans, and J K Boeijinga, and D D Breimer
December 1992, Therapeutic drug monitoring,
R Jochemsen, and J J Hogendoorn, and J Dingemanse, and J Hermans, and J K Boeijinga, and D D Breimer
June 2018, Journal of analytical toxicology,
R Jochemsen, and J J Hogendoorn, and J Dingemanse, and J Hermans, and J K Boeijinga, and D D Breimer
December 1994, Arzneimittel-Forschung,
R Jochemsen, and J J Hogendoorn, and J Dingemanse, and J Hermans, and J K Boeijinga, and D D Breimer
February 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
R Jochemsen, and J J Hogendoorn, and J Dingemanse, and J Hermans, and J K Boeijinga, and D D Breimer
December 1980, Journal of pharmaceutical sciences,
R Jochemsen, and J J Hogendoorn, and J Dingemanse, and J Hermans, and J K Boeijinga, and D D Breimer
June 1987, International journal of clinical pharmacology, therapy, and toxicology,
R Jochemsen, and J J Hogendoorn, and J Dingemanse, and J Hermans, and J K Boeijinga, and D D Breimer
December 1983, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!